Page 1226 - Veterinary Toxicology, Basic and Clinical Principles, 3rd Edition
P. 1226

Prevention and Treatment of Poisoning Chapter | 82  1157




  VetBooks.ir  membrane permeability, a decrease in cellular energy pro-  Pesillo et al., 2002). Pamidronate is also preferred to cal-
                                                                citonin since patients may become refractory to calcitonin
             duction and cellular necrosis (Morrow, 2001). Patients
             poisoned by vitamin D 3 and its analogs often present with
                                                                treatment after 10 days of therapy (Rumbeiha et al., 2000;
             polyuria, polydipsia, vomiting, anorexia, lethargy, hyper-  Morrow, 2001).
             calcemia and hyperphosphatemia (Pesillo et al., 2002). If
             elevations in serum calcium and phosphorus concentra-
             tions go unchecked, the plasma calcium phosphorus prod-  Phytonadione (Vitamin K 1 )
             uct (Ca 3 P) can rise above 60, leading to soft tissue
             mineralization (Morrow, 2001). Mineralization of the kid-  Phytonadione, a naphthoquinone derivative identical to
             neys and heart can lead to a life-threatening decrease in  naturally occurring vitamin K 1 , is used in the treatment of
             function of these organs.                          anticoagulant toxicosis resulting from anticoagulant
                Pamidronate acts to decrease serum calcium levels by  rodenticides, the medication warfarin or moldy sweet clo-
             binding to hydroxyapatite crystals in the bone to prevent  ver (Plumb, 2015). All household pets, including pocket
             their dissolution and bone resorption. It also interrupts  pets, may be exposed to anticoagulant rodenticides and
             osteoclast activity and induces osteoclast apoptosis  the medication warfarin. Livestock and horses are more
             (Plumb, 2015). Some authors suggest pamidronate may  likely to be poisoned by the dicoumarol in moldy sweet
             decrease intestinal absorption of calcium as well (Pesillo  clover, but they can also be exposed to rodenticides
             et al., 2002).                                     (Knight, 2004).
                The recommended dose of pamidronate is 1.3 2 mg/  Anticoagulants  block  clotting  factor  activation.
             kg given as a slow IV infusion over several hours  Vitamin K 1 is involved in the activation of precursor clot-
             (Plumb, 2015). Pamidronate must be given in saline and  ting factors into functional factors. During the activation,
             should not mix with any IV fluid containing calcium  vitamin K 1 is converted to inactive vitamin K 1 epoxide.
             (e.g., Ringer’s). In most cases, a single dose will be effec-  Normally, vitamin K 1 epoxide is reactivated by vitamin
             tive in lowering calcium levels back to normal     K 1 epoxide reductase. Anticoagulants work by inhibiting
             (Gwaltney-Brant and Rumbeiha, 2002). However, some  this enzyme and halting the recycling of vitamin K 1
             patients may require an additional dose 5 7 days after  (Merola, 2002). As a result, the number of active clotting
             the initial treatment (Morrow, 2001). Calcium levels  factors decreases.
             should be monitored once daily for at least 10 days after  The vitamin K 1 -dependent clotting factors are II, VII,
             they have returned to normal. Pamidronate is most effec-  IX, and X. These factors are involved in all three path-
             tive if given within 24 36 h of the exposure, prior to  ways of the coagulation system: the extrinsic, intrinsic,
             development of soft tissue mineralization (Gwaltney-  and common (Means, 2004a). Active bleeding is not
             Brant and Rumbeiha, 2002).                         expected for 3 7 days after the ingestion because the
                Anemia, thrombocytopenia and granulocytosis have  body has a reserve of active clotting factors. When these
             been reported in humans following pamidronate adminis-  degrade naturally or are consumed, clinical signs are pos-
             tration. In dogs, hypersensitivity reactions, electrolyte  sible. If an external source of vitamin K 1 is provided, the
             abnormalities including hypomagnesemia and hypocalce-  factors will be activated normally (Merola, 2002).
             mia, arrhythmias and renal toxicity are possible (Plumb,  Bleeding can occur anywhere within the body and the
             2015). Slow infusion of the drug over at least 2 h may  presenting clinical signs will relate to where the bleeding
             help in avoiding renal effects. Use of pamidronate in dogs  has occurred. The signs may be vague and nonspecific. In
             with impaired renal function is controversial since it may  dogs, dyspnea, coughing, lethargy, and hemoptysis are
             confound renal injury (Gwaltney-Brant and Rumbeiha,  commonly reported due to bleeding into the chest cavity
             2002).                                             (Merola, 2002). With moldy sweet clover poisoning in
                Pamidronate now comes in a generic form and its use  livestock, prolonged bleeding in some members following
             may be more cost effective than using salmon calcitonin  routine surgical procedures, like castration or dehorning,
             in vitamin D 3 toxicosis. Pamidronate lowers plasma cal-  is often the first indication of a problem within the herd
             cium concentrations within 24 48 h of a single IV dose.  (Knight, 2004).
             Calcitonin requires dosing several times daily due to its  The dose for vitamin K 1 in household pets is
             short half-life. Additionally, with calcitonin therapy,  1.5 2.5 mg/kg orally twice daily. Pocket pets and other
             saline diuresis, and treatment with diuretics and corticos-  small patients can be given the injectable formulation
             teroids must also be performed, requiring many days,  orally if a suitable tablet size is not available. Small
             sometimes multiple weeks, of hospitalization. In most  patients should be dosed at the high end of the range and
             cases treated with pamidronate, treatment can be per-  larger patients (e.g., large breed dogs) should be started at
             formed on an out-patient basis once the calcium    the low end (Means, 2004a). Vitamin K 1 should be given
             has returned to the normal range (Morrow, 2001;    with a fatty meal to enhance absorption. In dogs, giving
   1221   1222   1223   1224   1225   1226   1227   1228   1229   1230   1231